Bal Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue66.5975.1488.0283.8489.06
Expenses66.3874.4386.2280.6387.92
EBITDA6.786.859.8710.338.38
Operating Profit4.264.586.647.285.61
Profit Before Tax0.210.721.793.211.14
Net Profit0.210.721.793.601.14
Financial Ratios
Operating Profit Margin10.29%9.25%11.26%12.29%9.47%
Net Profit Margin0.30%0.96%2.03%4.27%1.26%
Earning Per Share (Diluted)0.130.451.122.260.71
Dividends Per Share0.000.000.000.000.00